Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.030
-0.110 (-9.65%)
At close: Feb 20, 2026, 4:00 PM EST
1.030
0.00 (0.00%)
After-hours: Feb 20, 2026, 4:04 PM EST
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $11.09 million as of February 20, 2026. Its market cap has increased by 13.78% in one year.
Market Cap
11.09M
Enterprise Value
1.57M
1-Year Change
13.78%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $11.09M, a decrease of -31.65%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 12.27M | 8.57% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.64M |
| Traws Pharma | 12.55M |
| Moolec Science | 12.42M |
| NewcelX | 12.40M |
| BioCardia | 12.31M |
| BioAtla | 12.20M |
| GT Biopharma | 12.16M |
| Longeveron | 11.95M |